Overexpression of CDC20 predicts poor prognosis in primary non-small cell lung cancer patients

Journal of Surgical Oncology, 05/04/2012

CDC20 was a negative prognostic marker with significance in patients with resected non–small cell lung cancer (NSCLC), particularly those with ADC histology. These results provide additional information for determining postoperative adjuvant treatment.

Print Article Summary Cat 2 CME Report